Micronization Capacity Additions - Need of the Hour

Business Case/Abstract Today's pharmaceutical market is competitive as never before. Regulators and payers are constantly looking for robust data to validate the drug's benefits. Hence, companies are seeking to improve the efficacy of the drug, reduce the cost of formulation, reduction in dosage requirement, etc., Micronization is a proven technology of reducing the particle size of active pharmaceutical ingredients (API) for increasing the bioavailability of the products. The particle size reduction is accomplished through collision of the different particles in air or nitrogen stream. Thus micronization as a process has helped improve the drug efficacy and in the reduction of dosages. Most companies have sparse internal capacity for Micronization. With increase in demand for micronization, companies are moving towards outsourcing to third party vendors. This increased demand for outsourcing which is more than anticipated has resulted in a situation where the supply demand gap is increasing slowly. This white paper will discuss about the problems revolving around the supply demand scenario for this technology and road ahead for pharmaceutical companies Discussion around possible players and markets for micronization and the need to look out for potential partner will be covered in the paper